Novartis CEO says any new coronavirus vaccine will take two years
Moderna has sped up plans for its experimental COVID-19 vaccine and said it expected to start a late-stage trial in early summer
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
vaccine
ICMR teams up with Bharat Biotech to develop COVID-19 vaccine
The vaccine will be developed using the virus strain isolated at the ICMR’s National Institute of Virology (NIV), Pune, a…
DBT-BIRAC COVID-19 research consortium recommends 70 proposals for funding in vaccines, diagnostics,…
The shortlisted proposals includes10 vaccines candidates, 34 diagnostics products or scale-up facilities, 10 therapeutics options,…
Valneva and Pfizer collaborate for Lyme disease vaccine
VLA15 is the only active Lyme disease vaccine programme in clinical development today, and covers six serotypes that are prevalent…
GBRC signs MoU with Neuberg Supratech for coronavirus vaccine
Neuberg Supratech will look for immune markers for the COVID-19 positive patients with the use of its in-house high throughput…
Viravaxx AG and Medical University of Vienna collaborate on a project for immune diagnosis and…
In a clinical study, which has already received ethics approval and will start very soon, sera from convalescent COVID-19 patients…
Medicago announces production of a viable vaccine candidate for COVID-19
The biopharma successfully produced Virus-Like Particles (VLP) of the coronavirus in just 20 days using proprietary plant-based…
Novel drug target may lead to universal antiviral vaccine
Researchers suggest that boosting levels of AGO4 could shore up the immune system to protect against multiple viruses A…
Serum Institute opens Rs 3000-crore vaccine facility in Pune
The facility is getting ready to export Made in India vaccines to regulated markets like Europe and the US and will produce…
GSK Pharma strengthens vaccine portfolio
GST implementation impacts GSK's June quarter performance